chr1-228166132-A-T
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PM5
The NM_001010867.4(IBA57):c.316A>T(p.Thr106Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000394 in 1,521,322 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T106A) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001010867.4 missense
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- multiple mitochondrial dysfunctions syndrome 3Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- hereditary spastic paraplegia 74Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152072Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000162 AC: 2AN: 123468 AF XY: 0.0000290 show subpopulations
GnomAD4 exome AF: 0.00000365 AC: 5AN: 1369250Hom.: 0 Cov.: 33 AF XY: 0.00000444 AC XY: 3AN XY: 675702 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152072Hom.: 0 Cov.: 34 AF XY: 0.0000135 AC XY: 1AN XY: 74282 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Multiple mitochondrial dysfunctions syndrome 3;C5568837:Hereditary spastic paraplegia 74 Uncertain:1
This variant is present in population databases (no rsID available, gnomAD 0.005%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Thr106 amino acid residue in IBA57. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 27785568, 28671726, 28803783, 32348839). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with IBA57-related conditions. This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 106 of the IBA57 protein (p.Thr106Ser). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at